Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.42%
Changement Mensuel
-18.98%
Evolution sur 6 mois
+32.78%
Changement Annuel
+17.73%
Clôture Précédente
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volume
70
Marchés
Actions des Marchés US
Soins de Santé
ZNTL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
71.27 M
71.81 M
71.95 M
72.14 M
72.25 M
—
Valuation ratios
Enterprise value
220.94 M
183.69 M
72.47 M
46.08 M
70.03 M
372.27 M
Price to earnings ratio
-1.52
-1.3
-0.51
-0.51
-0.73
-3.04
Price to sales ratio
6.39
3.19
4.21
3.07
4
14.47
Price to cash flow ratio
-1.49
-1.26
-0.75
-0.55
-0.81
-3.36
Price to book ratio
0.16
0.64
0.08
0.07
0.09
0.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.06
0.13
0.08
0.08
0.35
Return on equity %
0.11
0.08
0.16
0.1
0.11
0.45
Return on invested capital %
80.77
67.11
111.94
355.03
341.36
875.44
Gross margin %
—
100
—
—
—
—
Operating margin %
—
185.55
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
101.75
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.29
7.32
6.94
7.99
7.76
30
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.06
0
0
0
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.62
0.56
0.46
0.48
0.37
1.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.14
1.3
5.33
5.18
4.72
16.53
Net current asset value per share
5.63
5.43
4.78
4.33
4
18.54
Tangible book value per share
4.93
4.74
4.12
3.81
3.51
16.18
Working capital per share
4.86
4.69
4.09
3.79
3.48
16.05
Book value per share
4.98
4.74
4.12
3.81
3.51
16.18
Nouvelles
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
Diretor financeiro da Zentalis Pharmaceuticals vende ações no valor de US$ 7.875
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Preço-alvo da Zentalis Pharmaceuticals reduzido para US$ 2 pela Leerink Partners
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress